Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,930.00
-20.00 (-0.34%)
Last updated: Oct 10, 2025, 2:00 PM KST

Pharos iBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
78,32398,001191,588---
Upgrade
Market Cap Growth
-42.48%-48.85%----
Upgrade
Enterprise Value
68,76980,945164,210---
Upgrade
Last Close Price
6050.007570.0014830.00---
Upgrade
PB Ratio
6.045.276.76---
Upgrade
P/TBV Ratio
6.245.396.79---
Upgrade
Debt / Equity Ratio
0.020.010.010.02-0.04-0.68
Upgrade
Asset Turnover
---0.010.000.02
Upgrade
Quick Ratio
16.3016.2521.1516.060.560.86
Upgrade
Current Ratio
17.1016.7021.5716.530.570.88
Upgrade
Return on Equity (ROE)
-58.74%-44.97%-38.50%-1825.61%--
Upgrade
Return on Assets (ROA)
-38.33%-31.94%-26.12%-28.73%-23.78%-32.64%
Upgrade
Return on Capital (ROIC)
-39.57%-33.24%-27.09%-469.65%--
Upgrade
Earnings Yield
-13.44%-10.78%-4.62%---
Upgrade
FCF Yield
-11.55%-10.21%-4.31%---
Upgrade
Buyback Yield / Dilution
-2.28%-6.79%-36.26%-53.03%-2.65%-1.86%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.